Literature DB >> 32312779

Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112 Aspergillus Section Nigri Isolates.

B Carrara1, R Richards1, S Imbert1,2, F Morio3, M Sasso4, N Zahr5, A C Normand1, P Le Pape3, L Lachaud6, S Ranque7, D Maubon8, R Piarroux1,9, A Fekkar10,2.   

Abstract

Aspergillus niger, the third species responsible for invasive aspergillosis, has been considered as a homogeneous species until DNA-based identification uncovered many cryptic species. These species have been recently reclassified into the Aspergillus section Nigri However, little is yet known among the section Nigri about the species distribution and the antifungal susceptibility pattern of each cryptic species. A total of 112 clinical isolates collected from 5 teaching hospitals in France and phenotypically identified as A. niger were analyzed. Identification to the species level was carried out by nucleotide sequence analysis. The MICs of itraconazole, voriconazole, posaconazole, isavuconazole, and amphotericin B were determined by both the EUCAST and gradient concentration strip methods. Aspergillus tubingensis (n = 51, 45.5%) and Aspergillus welwitschiae (n = 50, 44.6%) were the most common species while A. niger accounted for only 6.3% (n = 7). The MICs of azole drugs were higher for A. tubingensis than for A. welwitschiae The MIC of amphotericin B was 2 mg/liter or less for all isolates. Importantly, MICs determined by EUCAST showed no correlation with those determined by the gradient concentration strip method, with the latter being lower than the former (Spearman's rank correlation tests ranging from 0.01 to 0.25 depending on the antifungal agent; P > 0.4). In conclusion, A. niger should be considered as a minority species in the section Nigri The differences in MICs between species for different azoles underline the importance of accurate identification. Significant divergences in the determination of MIC between EUCAST and the gradient concentration strip methods require further investigation.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Aspergillus section Nigri; amphotericin B; antifungal drugs; antifungal resistance; antifungal susceptibility testing; azoles; cryptic species; invasive aspergillosis; species complex

Mesh:

Substances:

Year:  2020        PMID: 32312779      PMCID: PMC7318033          DOI: 10.1128/AAC.02510-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.

Authors:  D T A Te Dorsthorst; J W Mouton; C J P van den Beukel; H A L van der Lee; J F G M Meis; P E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.

Authors:  Roberta Iatta; Federica Nuccio; Davide Immediato; Adriana Mosca; Carmela De Carlo; Giuseppe Miragliotta; Antonio Parisi; Giuseppe Crescenzo; Domenico Otranto; Claudia Cafarchia
Journal:  J Clin Microbiol       Date:  2016-07-13       Impact factor: 5.948

3.  Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins.

Authors:  Yali Li; Zhe Wan; Wei Liu; Ruoyu Li
Journal:  J Clin Microbiol       Date:  2014-12-10       Impact factor: 5.948

4.  Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds.

Authors:  Frédéric Lamoth; Barbara D Alexander
Journal:  J Clin Microbiol       Date:  2015-07-22       Impact factor: 5.948

5.  Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.

Authors:  Z Kamali Sarwestani; S J Hashemi; S Rezaie; M Gerami Shoar; S Mahmoudi; M Elahi; M Bahardoost; A Tajdini; S Abutalebian; R Daie Ghazvini
Journal:  J Mycol Med       Date:  2018-03-11       Impact factor: 2.391

6.  Species identification and antifungal susceptibility patterns of species belonging to Aspergillus section Nigri.

Authors:  Laura Alcazar-Fuoli; Emilia Mellado; Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

7.  Invasive Aspergillus niger complex infections in a Belgian tertiary care hospital.

Authors:  E Vermeulen; J Maertens; P Meersseman; V Saegeman; L Dupont; K Lagrou
Journal:  Clin Microbiol Infect       Date:  2013-11-04       Impact factor: 8.067

Review 8.  Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Fungi.

Authors:  Daisuke Hagiwara; Akira Watanabe; Katsuhiko Kamei; Gustavo H Goldman
Journal:  Front Microbiol       Date:  2016-09-21       Impact factor: 5.640

9.  Aspergillus labruscus sp. nov., a new species of Aspergillus section Nigri discovered in Brazil.

Authors:  Maria Helena P Fungaro; Larissa S Ferranti; Fernanda P Massi; Josué J da Silva; Daniele Sartori; Marta H Taniwaki; Jens C Frisvad; Beatriz T Iamanaka
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

10.  Aspergillus Species and Antifungals Susceptibility in Clinical Setting in the North of Portugal: Cryptic Species and Emerging Azoles Resistance in A. fumigatus.

Authors:  Eugénia Pinto; Carolina Monteiro; Marta Maia; Miguel A Faria; Virgínia Lopes; Catarina Lameiras; Dolores Pinheiro
Journal:  Front Microbiol       Date:  2018-07-23       Impact factor: 5.640

View more
  6 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

2.  Multicentric Analysis of the Species Distribution and Antifungal Susceptibility of Cryptic Isolates from Aspergillus Section Fumigati.

Authors:  S Imbert; A C Normand; S Cassaing; F Gabriel; L Kristensen; C Bonnal; L Lachaud; D Costa; J Guitard; L Hasseine; M Palous; M Piarroux; M Hendrickx; R Piarroux; A Fekkar
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

3.  Antifungal Susceptibility of 182 Fusarium Species Isolates from 20 European Centers: Comparison between EUCAST and Gradient Concentration Strip Methods.

Authors:  Marion Blaize; Anne-Cecile Normand; Sebastien Imbert; Abdullah M S Al-Hatmi; Erja Chryssanthou; Sophie Cassaing; Christine Schuttler; Lilia Hasseine; Caroline Mahinc; Damien Costa; Christine Bonnal; Stéphane Ranque; Marc Sautour; Elisa Rubio; Laurence Delhaes; Arnaud Riat; Boualem Sendid; Lise Kristensen; Marcel Brandenberger; Dirk Stubbe; Sophie Brun; Renaud Piarroux; Arnaud Fekkar
Journal:  Antimicrob Agents Chemother       Date:  2021-09-20       Impact factor: 5.191

4.  Identification of Molds with Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry: Performance of the Newly Developed MSI-2 Application in Comparison with the Bruker Filamentous Fungi Database and MSI-1.

Authors:  Anne-Cécile Normand; Marion Blaize; Sébastien Imbert; Ann Packeu; Pierre Becker; Arnaud Fekkar; Dirk Stubbe; Renaud Piarroux
Journal:  J Clin Microbiol       Date:  2021-07-28       Impact factor: 5.948

5.  A New Filter Based Cultivation Approach for Improving Aspergillus Identification using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS).

Authors:  Husam Salah; Anna Kolecka; Anna Rozaliyani; Retno Wahyuningsih; Saad J Taj-Aldeen; Teun Boekhout; Jos Houbraken
Journal:  Mycopathologia       Date:  2022-01-10       Impact factor: 2.574

Review 6.  Aspergillus tubingensis Endocarditis: A Case Report and Review of the Literature.

Authors:  Tristan Born; Marion Aruanno; Eleftheria Kampouri; Matteo Mombelli; Pierre Monney; Piergiorgio Tozzi; Frederic Lamoth
Journal:  Mycopathologia       Date:  2022-03-10       Impact factor: 3.785

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.